PROFIL PENGGUNAAN OBAT PADA PASIEN COVID-19 DI SALAH SATU RUMAH SAKIT DI BANJARMASIN

Yusrinie Wasiaturrahmah, Aditya Maulana Perdana Putra, Nahdha Nahdha, N. Rahmah
{"title":"PROFIL PENGGUNAAN OBAT PADA PASIEN COVID-19 DI SALAH SATU RUMAH SAKIT DI BANJARMASIN","authors":"Yusrinie Wasiaturrahmah, Aditya Maulana Perdana Putra, Nahdha Nahdha, N. Rahmah","doi":"10.36387/jifi.v5i1.917","DOIUrl":null,"url":null,"abstract":"Coronavirus 19, Knowing as COVID-19, is a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 treatment is still limited to supportive and oxygen therapy. The use of drugs is on the complaints felt by patients and comorbidities. This study aims to look at drug use profiles in COVID-19 patients. This research was included in descriptive research with a retrospective cross-sectional design. This research data was the entire prescription sheet and medical records of COVID-19 patients for March-August 2020 that meet the inclusion criteria. The result from collecting COVID-19 patient data for March-August 2020 obtained 114 medical records that met the criteria for research inclusion. Research Result: Characteristics of study subjects of the male sex are more infected with COVID-19. The age range with the highest number of COVID-19 patients was 46-55 years. Treatment profiles often used in COVID-19 patients are Supplements and Vitamins for 6538 prescriptions and Antibiotics for 2813 prescriptions. The most prescribed supplements and vitamins are Vitamin C, Lakto B, Zinc, and Vitamin C. The most prescribed antibiotics are Azithromycin, Meropenem, and Levofloxacin. The conclusion obtained in this study is that Supplements and vitamins, and Antibiotics are the most prescribed drug class.","PeriodicalId":306551,"journal":{"name":"Jurnal Insan Farmasi Indonesia","volume":"9 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jurnal Insan Farmasi Indonesia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36387/jifi.v5i1.917","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Coronavirus 19, Knowing as COVID-19, is a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 treatment is still limited to supportive and oxygen therapy. The use of drugs is on the complaints felt by patients and comorbidities. This study aims to look at drug use profiles in COVID-19 patients. This research was included in descriptive research with a retrospective cross-sectional design. This research data was the entire prescription sheet and medical records of COVID-19 patients for March-August 2020 that meet the inclusion criteria. The result from collecting COVID-19 patient data for March-August 2020 obtained 114 medical records that met the criteria for research inclusion. Research Result: Characteristics of study subjects of the male sex are more infected with COVID-19. The age range with the highest number of COVID-19 patients was 46-55 years. Treatment profiles often used in COVID-19 patients are Supplements and Vitamins for 6538 prescriptions and Antibiotics for 2813 prescriptions. The most prescribed supplements and vitamins are Vitamin C, Lakto B, Zinc, and Vitamin C. The most prescribed antibiotics are Azithromycin, Meropenem, and Levofloxacin. The conclusion obtained in this study is that Supplements and vitamins, and Antibiotics are the most prescribed drug class.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在BANJARMASIN的一家医院,COVID-19患者的药物使用情况
冠状病毒19 (COVID-19)是一种由严重急性呼吸综合征冠状病毒2 (SARS-CoV-2)引起的疾病。COVID-19的治疗仍然局限于支持和氧气治疗。药物的使用取决于患者的抱怨和合并症。这项研究旨在研究COVID-19患者的药物使用情况。本研究纳入回顾性横断面设计的描述性研究。本研究数据为符合纳入标准的2020年3月至8月2019冠状病毒病患者的全部处方和病历。通过收集2020年3月至8月的COVID-19患者数据,获得了114份符合研究纳入标准的病历。研究结果:研究对象的特点是男性感染COVID-19较多。新冠肺炎患者人数最多的年龄段为46-55岁。COVID-19患者经常使用的治疗方案是6538张处方的补充剂和维生素,2813张处方的抗生素。处方最多的补品和维生素是维生素C、维生素B、锌和维生素C。处方最多的抗生素是阿奇霉素、美罗培南和左氧氟沙星。本研究得出的结论是,补品和维生素、抗生素是处方最多的药物类别。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
AKTIVITAS PROTEASE EKSTRASELULER BAKTERI YANG DIISOLASI DARI LIMBAH CAIR INDUSTRI TAHU UJI AKTIVITAS ANTIDEPRESAN ISOMIRISTISIN TERHADAP IMMOBILITY TIME MENCIT PUTIH JANTAN (MUS MUSCULUS) UJI AKTIVITAS ENZIM SUPEROKSIDA DISMUTASE (SOD) EKSTRAK DAUN SALAM (Syzygium polyanthum) DENGAN METODE WATER SOLUBLE TETRAZOLIUM SALT-1 (WST-1) GAMBARAN PENGELOLAAN PERSEDIAAN PERBEKALAN FARMASI DAN BAHAN MEDIS HABIS PAKAI DI APOTEK HALIM MEDIKA BANJARBARU PERBANDINGAN HASIL PENETAPAN PARAMETER SPESIFIK DAN NON-SPESIFIK ANTARA SIMPLISIA TERHADAP EKSTRAK METANOL PURUN TIKUS (Eleocharis Dulcis)
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1